The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sodium Phenylbutyrate Market Research Report 2025
Synopsis
Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.
Global Sodium Phenylbutyrate market is projected to reach US$ 3023 million in 2029, increasing from US$ 1920 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Phenylbutyrate market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Phenylbutyrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lee's Pharmaceutical
Amylyx Pharma
Medunik
Par Pharma
Sigmapharm Laboratories
Alvogen
Horizon Therapeutics
Tobio Novelfarma
Orpharma
Investor AB
Medison Pharma Ltd.
Synageva BioPharma Corp
Swedish Orphan Biovitrum AB (Sobi)
Dipharma Francis Srl
Segment by Type
Tablets
Granules
Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Phenylbutyrate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.
Global Sodium Phenylbutyrate market is projected to reach US$ 3023 million in 2029, increasing from US$ 1920 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Phenylbutyrate market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Phenylbutyrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lee's Pharmaceutical
Amylyx Pharma
Medunik
Par Pharma
Sigmapharm Laboratories
Alvogen
Horizon Therapeutics
Tobio Novelfarma
Orpharma
Investor AB
Medison Pharma Ltd.
Synageva BioPharma Corp
Swedish Orphan Biovitrum AB (Sobi)
Dipharma Francis Srl
Segment by Type
Tablets
Granules
Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Phenylbutyrate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Sodium Phenylbutyrate Market Overview
1.1 Product Overview and Scope of Sodium Phenylbutyrate
1.2 Sodium Phenylbutyrate Segment by Type
1.2.1 Global Sodium Phenylbutyrate Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Granules
1.2.4 Powder
1.3 Sodium Phenylbutyrate Segment by Application
1.3.1 Global Sodium Phenylbutyrate Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sodium Phenylbutyrate Market Size Estimates and Forecasts
1.4.1 Global Sodium Phenylbutyrate Revenue 2018-2029
1.4.2 Global Sodium Phenylbutyrate Sales 2018-2029
1.4.3 Global Sodium Phenylbutyrate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sodium Phenylbutyrate Market Competition by Manufacturers
2.1 Global Sodium Phenylbutyrate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sodium Phenylbutyrate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sodium Phenylbutyrate Average Price by Manufacturers (2018-2023)
2.4 Global Sodium Phenylbutyrate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sodium Phenylbutyrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sodium Phenylbutyrate, Product Type & Application
2.7 Sodium Phenylbutyrate Market Competitive Situation and Trends
2.7.1 Sodium Phenylbutyrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sodium Phenylbutyrate Players Market Share by Revenue
2.7.3 Global Sodium Phenylbutyrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sodium Phenylbutyrate Retrospective Market Scenario by Region
3.1 Global Sodium Phenylbutyrate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sodium Phenylbutyrate Global Sodium Phenylbutyrate Sales by Region: 2018-2029
3.2.1 Global Sodium Phenylbutyrate Sales by Region: 2018-2023
3.2.2 Global Sodium Phenylbutyrate Sales by Region: 2024-2029
3.3 Global Sodium Phenylbutyrate Global Sodium Phenylbutyrate Revenue by Region: 2018-2029
3.3.1 Global Sodium Phenylbutyrate Revenue by Region: 2018-2023
3.3.2 Global Sodium Phenylbutyrate Revenue by Region: 2024-2029
3.4 North America Sodium Phenylbutyrate Market Facts & Figures by Country
3.4.1 North America Sodium Phenylbutyrate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sodium Phenylbutyrate Sales by Country (2018-2029)
3.4.3 North America Sodium Phenylbutyrate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sodium Phenylbutyrate Market Facts & Figures by Country
3.5.1 Europe Sodium Phenylbutyrate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sodium Phenylbutyrate Sales by Country (2018-2029)
3.5.3 Europe Sodium Phenylbutyrate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sodium Phenylbutyrate Market Facts & Figures by Country
3.6.1 Asia Pacific Sodium Phenylbutyrate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sodium Phenylbutyrate Sales by Country (2018-2029)
3.6.3 Asia Pacific Sodium Phenylbutyrate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sodium Phenylbutyrate Market Facts & Figures by Country
3.7.1 Latin America Sodium Phenylbutyrate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sodium Phenylbutyrate Sales by Country (2018-2029)
3.7.3 Latin America Sodium Phenylbutyrate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sodium Phenylbutyrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Sodium Phenylbutyrate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sodium Phenylbutyrate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sodium Phenylbutyrate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sodium Phenylbutyrate Sales by Type (2018-2029)
4.1.1 Global Sodium Phenylbutyrate Sales by Type (2018-2023)
4.1.2 Global Sodium Phenylbutyrate Sales by Type (2024-2029)
4.1.3 Global Sodium Phenylbutyrate Sales Market Share by Type (2018-2029)
4.2 Global Sodium Phenylbutyrate Revenue by Type (2018-2029)
4.2.1 Global Sodium Phenylbutyrate Revenue by Type (2018-2023)
4.2.2 Global Sodium Phenylbutyrate Revenue by Type (2024-2029)
4.2.3 Global Sodium Phenylbutyrate Revenue Market Share by Type (2018-2029)
4.3 Global Sodium Phenylbutyrate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sodium Phenylbutyrate Sales by Application (2018-2029)
5.1.1 Global Sodium Phenylbutyrate Sales by Application (2018-2023)
5.1.2 Global Sodium Phenylbutyrate Sales by Application (2024-2029)
5.1.3 Global Sodium Phenylbutyrate Sales Market Share by Application (2018-2029)
5.2 Global Sodium Phenylbutyrate Revenue by Application (2018-2029)
5.2.1 Global Sodium Phenylbutyrate Revenue by Application (2018-2023)
5.2.2 Global Sodium Phenylbutyrate Revenue by Application (2024-2029)
5.2.3 Global Sodium Phenylbutyrate Revenue Market Share by Application (2018-2029)
5.3 Global Sodium Phenylbutyrate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Lee's Pharmaceutical
6.1.1 Lee's Pharmaceutical Corporation Information
6.1.2 Lee's Pharmaceutical Description and Business Overview
6.1.3 Lee's Pharmaceutical Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Lee's Pharmaceutical Sodium Phenylbutyrate Product Portfolio
6.1.5 Lee's Pharmaceutical Recent Developments/Updates
6.2 Amylyx Pharma
6.2.1 Amylyx Pharma Corporation Information
6.2.2 Amylyx Pharma Description and Business Overview
6.2.3 Amylyx Pharma Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amylyx Pharma Sodium Phenylbutyrate Product Portfolio
6.2.5 Amylyx Pharma Recent Developments/Updates
6.3 Medunik
6.3.1 Medunik Corporation Information
6.3.2 Medunik Description and Business Overview
6.3.3 Medunik Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medunik Sodium Phenylbutyrate Product Portfolio
6.3.5 Medunik Recent Developments/Updates
6.4 Par Pharma
6.4.1 Par Pharma Corporation Information
6.4.2 Par Pharma Description and Business Overview
6.4.3 Par Pharma Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Par Pharma Sodium Phenylbutyrate Product Portfolio
6.4.5 Par Pharma Recent Developments/Updates
6.5 Sigmapharm Laboratories
6.5.1 Sigmapharm Laboratories Corporation Information
6.5.2 Sigmapharm Laboratories Description and Business Overview
6.5.3 Sigmapharm Laboratories Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sigmapharm Laboratories Sodium Phenylbutyrate Product Portfolio
6.5.5 Sigmapharm Laboratories Recent Developments/Updates
6.6 Alvogen
6.6.1 Alvogen Corporation Information
6.6.2 Alvogen Description and Business Overview
6.6.3 Alvogen Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Alvogen Sodium Phenylbutyrate Product Portfolio
6.6.5 Alvogen Recent Developments/Updates
6.7 Horizon Therapeutics
6.6.1 Horizon Therapeutics Corporation Information
6.6.2 Horizon Therapeutics Description and Business Overview
6.6.3 Horizon Therapeutics Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Horizon Therapeutics Sodium Phenylbutyrate Product Portfolio
6.7.5 Horizon Therapeutics Recent Developments/Updates
6.8 Tobio Novelfarma
6.8.1 Tobio Novelfarma Corporation Information
6.8.2 Tobio Novelfarma Description and Business Overview
6.8.3 Tobio Novelfarma Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tobio Novelfarma Sodium Phenylbutyrate Product Portfolio
6.8.5 Tobio Novelfarma Recent Developments/Updates
6.9 Orpharma
6.9.1 Orpharma Corporation Information
6.9.2 Orpharma Description and Business Overview
6.9.3 Orpharma Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Orpharma Sodium Phenylbutyrate Product Portfolio
6.9.5 Orpharma Recent Developments/Updates
6.10 Investor AB
6.10.1 Investor AB Corporation Information
6.10.2 Investor AB Description and Business Overview
6.10.3 Investor AB Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Investor AB Sodium Phenylbutyrate Product Portfolio
6.10.5 Investor AB Recent Developments/Updates
6.11 Medison Pharma Ltd.
6.11.1 Medison Pharma Ltd. Corporation Information
6.11.2 Medison Pharma Ltd. Sodium Phenylbutyrate Description and Business Overview
6.11.3 Medison Pharma Ltd. Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medison Pharma Ltd. Sodium Phenylbutyrate Product Portfolio
6.11.5 Medison Pharma Ltd. Recent Developments/Updates
6.12 Synageva BioPharma Corp
6.12.1 Synageva BioPharma Corp Corporation Information
6.12.2 Synageva BioPharma Corp Sodium Phenylbutyrate Description and Business Overview
6.12.3 Synageva BioPharma Corp Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Synageva BioPharma Corp Sodium Phenylbutyrate Product Portfolio
6.12.5 Synageva BioPharma Corp Recent Developments/Updates
6.13 Swedish Orphan Biovitrum AB (Sobi)
6.13.1 Swedish Orphan Biovitrum AB (Sobi) Corporation Information
6.13.2 Swedish Orphan Biovitrum AB (Sobi) Sodium Phenylbutyrate Description and Business Overview
6.13.3 Swedish Orphan Biovitrum AB (Sobi) Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Swedish Orphan Biovitrum AB (Sobi) Sodium Phenylbutyrate Product Portfolio
6.13.5 Swedish Orphan Biovitrum AB (Sobi) Recent Developments/Updates
6.14 Dipharma Francis Srl
6.14.1 Dipharma Francis Srl Corporation Information
6.14.2 Dipharma Francis Srl Sodium Phenylbutyrate Description and Business Overview
6.14.3 Dipharma Francis Srl Sodium Phenylbutyrate Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Dipharma Francis Srl Sodium Phenylbutyrate Product Portfolio
6.14.5 Dipharma Francis Srl Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sodium Phenylbutyrate Industry Chain Analysis
7.2 Sodium Phenylbutyrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sodium Phenylbutyrate Production Mode & Process
7.4 Sodium Phenylbutyrate Sales and Marketing
7.4.1 Sodium Phenylbutyrate Sales Channels
7.4.2 Sodium Phenylbutyrate Distributors
7.5 Sodium Phenylbutyrate Customers
8 Sodium Phenylbutyrate Market Dynamics
8.1 Sodium Phenylbutyrate Industry Trends
8.2 Sodium Phenylbutyrate Market Drivers
8.3 Sodium Phenylbutyrate Market Challenges
8.4 Sodium Phenylbutyrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
